Would be darkly hilarious if the financial cost of semaglutides is what actually contributes to the weight loss.
Ozempic is currently the NVIDIA of the pharmaceutical industry.
In the same vein folks were disputing the validity of vitamin C until WWII [1].
There is no shortcut to science. You have to weigh the evidence. Currently, the evidence in favour of GLP-1 agonists is overwhelmingly positive.
As for longer term consequences? Who knows?
What’s an example of such a study?
It’s nearly 100 years old and widely used after Pseudoephedrine was more restricted so people couldn’t make meth as easily.
Yet, studies not conducted by pharmaceutical manufacturers find it mostly ineffective. Of course, the drug companies publish studies showing it to be effective…
Have you ever taken each (not together)? I’ve never heard someone say Phenylephrine did anything for them. Anecdotally, it’s utterly useless for me…
I suspect drug companies didn’t want restriction of Pseudoephedrine to decrease sales, so they pushed crap forward to maintain revenue.
(Yes, it still isn’t all that hard to get Pseudoephedrine, but one can’t just pick it off the shelf — a significant mental barrier)